SCHEMBL15977853

SCHEMBL15977853

c1ccc(-c2ccccc2-c2c3ccccc3c(-c3ccccc3-c3ccccc3)c3cc(-c4ccc(-c5ccncc5)cc4)ccc23)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 2/20 0.55
IMPDH2 P12268 2/20 0.54
MKNK1 Q9BUB5 1/20 0.49
NOTUM Q6P988 1/20 0.48
ALDH1A1 P00352 3/20 0.42
MAPT P10636 3/20 0.42
TSHR P16473 1/20 0.42
HTT P42858 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
DHODH Q02127 1/20 0.41
CHEK1 O14757 3/20 0.41
KDM4E B2RXH2 2/20 0.40
ALK Q9UM73 1/20 0.40
HPGD P15428 1/20 0.40
PRKCI P41743 1/20 0.40
MAPK1 P28482 2/20 0.39
MEN1 O00255 1/20 0.39
LMNA P02545 1/20 0.39
RECQL P46063 1/20 0.39
KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10030028 0.90 PIK3CA (0.51) PIK3CAIMPDH2MKNK1NOTUMALDH1A1
SCHEMBL10030025 0.89 PIK3CA (0.51) PIK3CAIMPDH2MKNK1NOTUMALDH1A1
SCHEMBL2966882 0.88 GPR84 (0.40) PIK3CAIMPDH2ALDH1A1MAPTHTT
SCHEMBL18174579 0.87 PIK3CA (0.49) PIK3CAIMPDH2MKNK1NOTUMALDH1A1
SCHEMBL15977469 0.86 NOTUM (0.56) PIK3CAIMPDH2MKNK1NOTUMMAPT
SCHEMBL10030021 0.86 NOTUM (0.56) PIK3CAIMPDH2MKNK1NOTUMMAPT
SCHEMBL10030050 0.86 NOTUM (0.56) PIK3CAIMPDH2MKNK1NOTUMMAPT
SCHEMBL29774095 0.86 NOTUM (0.56) PIK3CAIMPDH2MKNK1NOTUMMAPT
SCHEMBL10300979 0.86 NOTUM (0.56) PIK3CAIMPDH2MKNK1NOTUMMAPT
SCHEMBL13158596 0.86 NOTUM (0.56) PIK3CAIMPDH2MKNK1NOTUMMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220416178-A1 COMPOSITION, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS IDEMITSU KOSAN CO.,LTD. (JP) 2022-12-29 US disclosed
US-9559311-B2 Anthracene derivative, organic-electroluminescence-device material, organic electroluminescence device, and electronic equipment IDEMITSU KOSAN CO., LTD. (JP) 2017-01-31 US disclosed
US-9559311-B2 Anthracene derivative, organic-electroluminescence-device material, organic electroluminescence device, and electronic equipment IDEMITSU KOSAN CO., LTD. (JP) 2017-01-31 US disclosed
US-20140239273-A1 ANTHRACENE DERIVATIVE, ORGANIC-ELECTROLUMINESCENCE-DEVICE MATERIAL, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC EQUIPMENT IDEMITSU KOSAN CO., LTD. (JP) 2014-08-28 US disclosed
US-20140239273-A1 ANTHRACENE DERIVATIVE, ORGANIC-ELECTROLUMINESCENCE-DEVICE MATERIAL, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC EQUIPMENT IDEMITSU KOSAN CO., LTD. (JP) 2014-08-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220416178-A1 COMPOSITION, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS PIEZO1, TMEM109, SLC39A14 PIK3CA 2722/4885IMPDH2 3647/4885MKNK1 3333/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.